Gaq signaling is required for the maintenance of MLL-AF9-induced acute myeloid leukemia
Jodi Lynch(Cancer Institute of New South Wales), Jenny Wang(Columbia University Irving Medical Center), Estrella Gonzales‐Aloy(Cancer Institute of New South Wales), Hangyu Yi(Cancer Institute of New South Wales), Tsz Kan Fung(King's College London), Florida Voli(Cancer Institute of New South Wales), Richard J. D’Andrea(South Australia Pathology), Chi Wai Eric So(London Cancer), Anna Brown(South Australia Pathology), Michelle Haber(Cancer Clinic), Tao Liu(Cancer Clinic), Baohua Liu(Shenzhen University), Murray D. Norris(Cancer Clinic), Ian D. Lewis, Débora A. Casolari(South Australia Pathology)
Cited by 10
Related Papers
Genomic instability in laminopathy-based premature aging
|Nature Medicine|2005|641
Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial
|The Lancet|2017|580
Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research
|Biology of Blood and Marrow Transplantation|2014|435
Ischemia in Tumors Induces Early and Sustained Phosphorylation Changes in Stress Kinase Pathways but Does Not Affect Global Protein Levels
|Molecular & Cellular Proteomics|2014|419